Myocardial infarction (MI) care pathways should implement early combination therapy with statins plus ezetimibe as standard care, according to findings from an observational study published April 14 ...

Real-world low-risk patients undergoing TAVR have a greater risk of adverse events at one year, particularly mortality, when compared with published clinical trial data, according to a study published ...

Achieving and maintaining a healthy weight before pregnancy may be instrumental in promoting maternal health and reducing future heart disease risk, according to findings from an observational study ...

A state-of-the-art review published in JACC aims to serve as a primary reference for clinicians providing cardiovascular care to pediatric athletes, defined as individuals aged 5 to 17 years who ...

Time is running out to apply for the next NP/PA Certified Cardiovascular Knowledge (CCK) Examination! Monday, April 21 is the last day to apply for the online exam, which can be taken between May 1-4 ...

Tiny fragments of plastic have become ubiquitous in our environment and our bodies. Higher exposure to these microplastics, which can be inadvertently consumed or inhaled, is associated with a ...

In addition to causing several types of cancer, human papillomavirus (HPV) appears to bring a significantly increased risk of heart disease and coronary artery disease, according to a study being ...

The ALIGN-AR trial contributes to the literature by demonstrating high technical success, a reassuring safety profile, and favorable clinical outcomes in high-risk patients with aortic regurgitation ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...

The Advance-HTN trial showed that lorundrostat effectively lowered 24-hour SBP at 12 weeks among patients with uncontrolled and treatment-resistant hypertension vs. placebo. Participants at 103 U.S.

Join ACC's Prevention of Cardiovascular Disease Member Section this Wednesday, April 9 at 1 p.m. ET for a recap of ACC.25 prevention content and its influence on clinical practice. The webinar will ...

Clopidogrel monotherapy was found to be more effective than aspirin monotherapy in lowering risk of major adverse cardiac and cerebrovascular events among patients at high risk of recurrent ischemic ...